Metraipolis › archive › dc_2eb16da8dd7f

Osteoporosis treatment gap prior to femoral fracture and prevalence of pharmacological risk factors: a prospective observational study — Europe PMC PMID:42397594

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42397594
DOI
10.1007/s00402-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-10-18T11:40:31.350Z
SHA-256 of the archived text
121506cda4dfac0a97e5d1768b9d246d808a1f37adf9faa861ab88c787719c6e
Stable URL of this page
https://metraipolis.com/documento/dc_2eb16da8dd7f

How to cite

Osteoporosis treatment gap prior to femoral fracture and prevalence of pharmacological risk factors: a prospective observational study — Europe PMC PMID:42397594 — Europe PMC (en), https://europepmc.org/article/MED/42397594 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2eb16da8dd7f (Metraipolis archive dc_2eb16da8dd7f, sha256 121506cda4dfac0a97e5d1768b9d246d808a1f37adf9faa861ab88c787719c6e)
BibTeX
@misc{dc2eb16da8dd7f,
  title = {Osteoporosis treatment gap prior to femoral fracture and prevalence of pharmacological risk factors: a prospective observational study — Europe PMC PMID:42397594},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42397594},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2eb16da8dd7f; sha256 121506cda4dfac0a97e5d1768b9d246d808a1f37adf9faa861ab88c787719c6e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42397594. Agents can read the archived copy with the MCP tool read_document.